medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2011, Number 3

Next >>

Rev Biomed 2011; 22 (3)

Trypanosoma cruzi antibodies in humans and dogs, and the presence of parasite in Meccus pallidipennis in Pantitlán Puente, Morelos, Mexico

Portugal-García C, García-Vázquez Z, Monteón-Padilla V, Chávez-López V, Olamendi-Portugal M, Ramos C

Language: Spanish
References: 60
Page: 67-75
PDF size: 180.21 Kb.


ABSTRACT

Introduction. Chagas disease (CD) is endemic in Latin-American countries, including Mexico. In the state of Morelos, Mexico, past epidemiological studies have confirmed the relevance of CD.
Objective. To detect antibodies against T. cruzi in blood of humans and dogs, and to determine parasites in Triatominae in the community of Puente Pantitlan, Morelos.
Materials and Methods. This was a pilot transversal study performed during the period of October 2003 to October 2004. Sampling was conducted in 74 households; 233 blood samples were obtained from persons › 5 years old and 33 blood samples from dogs; and triatomines were collected to for taxonomic classification and to detect parasites. Antibodies against T. cruzi in humans were determined by ELISA and indirect immunofluorescence (IF), and by ELISA in dogs. Parasites in Triatominae feces were observed by optic microscopy.
Results. Seroprevalence was 1.2% (3/233) in humans and 24.2% (8/33) in dogs. Meccus pallidipennis was the only triatomine captured. They were found to have a 44% (8/18) CD infection rate. Thirteen out 74 households had positive CD cases in humans, dogs or triatomines.
Conclusions. These findings confirm the relevance of Chagas disease in a temperate rural community of the State of Morelos located 1,630 meters above sea level.


REFERENCES

  1. World Health Organization Expert Committee. Control of Chagas disease. World Health Organ Tech Rep Ser 2002; 905:1-109.

  2. Guzman-Bracho C. Epidemiology of Chagas disease in Mexico: an update. Trends in Parasitol 2001; 17:372-76.

  3. Velasco-Castrejón O, Guzmán BC, Ibáñez- Bernal S. Enfermedad de Chagas en: Enfermedades Tropicales en México. Instituto Nacional de Referencia Epidemiológica 1994. p. 279-92.

  4. Duffy T, Bisio M, Altcheh J, Burgos JM, Diez M, Levin MJ, et al Accurate Real-Time PCR Strategy for Monitoring Bloodstream Parasitic Loads in Chagas Disease Patients. PLOS Negl Trop Dis 2009; 3:419.

  5. Barbu C, Dumonteil E, Gourbiere S. Optimization of Control Strategies for Non-Domiciliated Triatoma dimidiata, Chagas Disease Vector in the Yucatán Peninsula, Mexico. PLOS Negl Trop Dis 2009; 3:416.

  6. López-Antuñano FJ. Quimioterapia de las infecciones producidas por Trypanosoma cruzi. Salud Púb Méx 1997; 42:463-71.

  7. World Health Organization. Control of Chagas´disease – Report of a WHO Expert Committee. Technical report series 1991; 811:9-10 Geneva.

  8. Wendel S, Brener Z, Camargo ME. Chagas´disease (American Tripanosomiasis): Its impact on transfusión and clinical medicine. Sao Paulo 1992. Ed ISBT 92:1-3.

  9. Signori PK, Schmidt FL, Guaraldo AMA, Franco RMB, Dias VL, Passos LAC. Chagas’ disease as a Foodborne Illness. J Food Protec 2009; 72: 441–46

  10. Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz. 2007; 102:75-85.

  11. Sandoval-Ruiz C, Zumaquero-Rios J, Linalres G, Alejandre Aguilar R, Cedillo Ramírez ML y López Olguin JF. Infección natural con Trypanosoma cruzi en triatominos (Hemiptera: Reduviidae: Triatominae), vectores de la enfermedad de Chagas en San Antonio Rayón, Jonotla, Puebla, México. Ver Tec Panama 2004; 6:39-47.

  12. Bautista N, Rojas G, De Haro I, Bucio M y Salazar Schettino PM. Biological behavior of Triatoma pallidipennis (Hemiptera: Reduviidae) in the State of Morelos, México. Bol Chil Parasitol 2001; 57:3-4.

  13. Schoeld JC, Diotaiut L, Dujardin JP. The process of domestication in triatominae. Mem Inst Oswaldo Cruz 1999; 94:375-79.

  14. Magallon-Gastelun E, Magdaleno-Peñaloza NC, Katthain-Duchateau G, Trujillo-Contreras F, Lozano-Kasten FJ, Hernández-Gutiérrez RJ. Distribution of Chagas´disease vectors (Hemíptera: Ruduviidae: Triatominae), in the state of Jalisco, Mexico. Rev Biomed 1998; 9:151-57.

  15. Gómez-Hernández C, Rezende-Oliveira K, Cortéz- Zárate A, Cortéz-Zárate E, Trujillo-Contreras F, Ramirez LE. Prevalência de triatomíneos (Hemíptera: Reduviidae: Triatominae) infectados por Trypanosoma cruzi: sazonalidade e distribuicao na regiao Ciénega do Estado de Jalisco, México. Ver Soc Bras Med Trop 2008; 41:257-62.

  16. Ruiz-Piña H, Cruz-Reyes A. The Opossum didelphys virginiana as a Synanthropic Reservoir of Trypanosoma cruzi in Dzidzilché, Yucatán, México. Mem Inst Oswaldo Cruz 2002; 95:613-20.

  17. Velasco O, Valdespino L, Tapia C. Seroepidemiología de la enfermedad de Chagas en México. Salud Pública Méx 1992; 34:186–96.

  18. Biagi F, Tay J, Guzmán C, Fong F. Tetitlán Guerrero: foco endémico de la enfermedad de Chagas. Rev Fac Med UNAM (México) 1964; 6:625–31.

  19. Quintal R, Zavala J, Rodríguez M. La enfermedad de Chagas en el estado de Yucatán, México. Rev Invest Clin 1975; 27:255–8.

  20. Tay J, Salazar-Schettino PM, Velasco CM, De Haro I, García YY, Gutierrez QM. Estudio epidemiológico de la enfermedad de Chagas en el estado de Jalisco, República Mexicana. Salud Pública Méx 1979; 20:145–9.

  21. Goldsmith RS, Kagan IG, Zárate R, Reyes G, Cedeño-Ferreira J. Estudios epidemiológicos de la enfermedad de Chagas en Oaxaca, México. Bol Oficina Sanit Panam 1979; 87:1–19.

  22. Goldsmith RS, Ortega M, Zárate R, Zárate L, Beltrán F. Seroepidemiologic surveys for Chagasdisease in Chiapas, México. Arch Invest Med 1983; 14:43–50.

  23. Salazar Schettino PM, Tay J, Ruiz A, Haro I de, Bucio M, Jiménez J, et al. Seropositividad a Trypanosoma cruzi en cuatro grupos de población del estado de Oaxaca. Rev Salud Pública Mex 1984; 26:589–95.

  24. Cortés JM, Velasco O, Labastida M, Melchor A, Duarte N, De Torre R. La enfermedad de Chagas en Santiago Yosotiche, Oaxaca, México. Salud Pública Méx 1985; 2:60–5.

  25. Sánchez B. Miocardiopatía crónica e infección por Trypanosoma cruzi en una localidad de Morelos y Tabasco [tesis de maestría]. México, D.F. Universidad Nacional Autónoma de México; 1988.

  26. Rodrigues Coura J, Albajar P. Chagas disease: a new worldwide challenge. Nature 2010; 465: S6-7.

  27. Rangel-Flores H, Sanchez B, Mendoza-Duarte J, Barnabe C, Breniere SF, Ramos C, et al. Serologic and parasitologic demostration of Trypanosoma cruzi infections in urban of central Mexico: Correlation with electrocardiographic alterations. Am J Trop Med Hyg 2001; 65:887-95.

  28. Rangel H, Gatica R, Ramos C. Detection of antibodies against Trypanosoma cruzi in donors from a blood bank in Cuernavaca Morelos, Mexico. Arch Med Res 1998; 29:79-82.

  29. Gaona-Bernal J. Diagnostico de la infección por Trypanosoma cruzi en individuos del Estado de Morelos con riesgo de desarrollar la enfermedad de Chagas. Tesis de Licenciatura, Facultad de Ciencias Biológicas, Universidad Autónoma del Estado de Morelos; 2003.

  30. Zepeda-Mendoza K. Detección de anticuerpos contra Trypanosoma cruzi en individuos que radican en el Estado de Morelos. Tesis de Licenciatura, Facultad de Ciencias Biológicas, Universidad Autónoma del Estado de Morelos; 2000.

  31. Chávez–López V. Tesis de Maestría: Estudio de la Enfermedad de Chagas en niños de Progreso, Jiutepec, Morelos, México. Facultad de Ciencias Agropecuarias. Universidad Autónoma del Estado de Morelos; 2005.

  32. García-Vazquez Z, Rosario-Cruz R, Miranda- Miranda E, Dominguez-Marquez A. A Serological survey of Trypanosoma cruzi: infection in dogs of two urban areas of México. Pre Vet Med 1995; 25:1-6

  33. Estrada-Franco JG, Bhatia V, Diaz-Albiter H, Ochoa-García L, Barbabosa A, Vazquez-Chagoyan JC, et al. Human Trypanosoma cruzi infection and seropositivity in dogs, Mexico. Emerging Infect Dis 2006; 12:624- 630.

  34. Ortega-Pacheco A, Rodriguez-Buenfil JC, Bolio- Gonzalez ME, Sauri-Arceo CH, Jiménez-Coello M, Linde Forsberg C. A Survey of Dog Populations in Urban and Rural Areas of Yucatan, Mexico. Anthrozoos 2007b; 20:261-274.

  35. INEGI 2000. XII Censo General de Población y Vivienda.

  36. Sosa-Jurado F, Zumaquero-Ríos JL, Reyes PA, Cruz-García A, Guzmán-Bracho C, Monteón VM. Factores bióticos y abióticos que determinan la seroprevalencia de anticuerpos contra Trypanosoma cruzi en el municipio de Palmar de Bravo, Puebla, México. Salud Pública Méx 2004; 46:39-48.

  37. Camargo ME, Segura E, Kagan IG, Pacheco-Souza JM, Carvalheiro JR, Yanovsky JF. Normalización del diagnóstico serológico de la enfermedad de Chagas en las Américas; evaluación de tres años de colaboración. Bol Oficina Sanit Panam 1987; 102:449-63.

  38. Monteón-Padilla VM, Sosa T, Reyes-López PA. Serological test for American tripanosomiasis: A comparative study. Rev Lat Microbiol Mex 1989; 31:35-38.

  39. Lent H y Wigodzinsky P. Revision of triatominae (Hemiptera: Reduviidae), and their significance as vector of Chagas disease. Bull Am Mus Nat Hist 1979; 163:124-520.

  40. Monteón V, Godínez S, Cruz-Zetina G, Balmes J, López R, Hernández O. Caracterización biológica de aislados mexicanos de Trypanosoma cruzi: Metaciclogénesis, parasitemia y resistencia contra benznidazol. Rev Biomed 2009; 20:206-21.

  41. Ramos-Ligonio A, López-Monteon A, Guzmán- Gómez D, Rosales-Encina JL, Limón-Flores Y, Dumonteil E. Identification of a Hyperendemic Area for Trypanosoma cruzi Infection in Central Veracruz, Mexico. Am J Trop Med Hyg 2010; 83:164–170

  42. Salazar PM, Rojas G, Bucio M, Cabrera M, García G, Ruíz A, et al Seroprevalencia de anticuerpos contra Trypanosoma cruzi y su asociación con factores de riesgo en menores de 18 años de Veracruz, México. Rev Panam Salud Pública 2007; 22:75-82.

  43. Turriago GBC, Vallejo GA y Guhl F. Seroprevalencia de Trypanosoma cruzi en perros de dos áreas endémicas de Colombia. Rev Fac Med 2008; 16:11-18.

  44. Gurtler RE, Céceres MC, Rubel DN, Petersen RM, Schweigman NI, Lauricella Ma et al. Chagas disease in north-west Argentina: Infected dogs as a risk factor for the domestic transmission of Trypanosoma cruzi. Trans R Soc Trop Med Hyg 1991; 85:741-45.

  45. Gurtler RE, Petersen RM, Lauricella MA, Wisnivesky-Colli C. Infectivity to the vector Triatoma infestans of dogs infected with Trypanosoma cruzi in north-west Argentina. Amp Trop Med Parasitol 1992; 86:111-19.

  46. Mott KE, Mota EA, Sherlock I, Hoff R, Muñiz TM, Oliveira TS, et al. Trypanosoma cruzi Infection in dogs and cats and household seroreactivity to T. cruzi in a rural community in northeast Brazil. Amp J Trop Med Hyg 1978; 27:1123-27.

  47. Rojas ME, Vázquez P, Villareal MF, Velandia C, Vergara L, Morán-Borges, et al. Estudio seroepidemiológico y entomológico sobre la enfermedad de Chagas en una área infestada por Triatoma maculata (Erichson 1848) en el centro-occidental de Venezuela. Cau Saúde Pública. Rio de Janeiro 2008; 24:2323-33.

  48. Reyes L, Silesky E, Cerdas C, Chinchilla M, Guerrero O. Presencia de anticuerpos contra Trypanosoma cruzi en perros de Costa Rica. Parasitol Latinoam 2002; 57:1-2.

  49. Montenegro VM, Jiménez M, Pinto JC, Zeledón R. Chagas Disease in Dogs from Endemic Areas of Costa Rica. Mem Inst Oswaldo Cruz 2002; 97:491-94.

  50. Jiménez-Coello M, Poot-Cob M, Ortega-Pacheco A, Guzman-Marin E, Ramos-Ligonio A, Sauri-Arceo CH, et al. American Tripanosomiasis in dogs from an urban and rural area of Yucatan, Mexico. Vet Borne Zoo Dis 2008; 8:755-62.

  51. Cruz-chan JV, Bolio-González M, Colín-Flores R, Ramírez-Sierra MJ, Quijano-Hernández I, Dumonteil E. Inmunopathology of natural infection with Trypanosoma cruzi in dogs. Vet Parasitol 2009; 162:151-55.

  52. Lauricella MA, Castañeda MB, Gurtler RE, Segura EL. Inmunodiagnosis of Trypanosoma cruzi (Chagas´Disease) Infection in naturally infected dogs. Mem Inst Oswaldo Cruz 1998; 93:501-07.

  53. Gurtler RE, Cecere MC, Lauricella MA, Cardinal MV, Kitron U, Cohen JE. Domestic dogs and cats as sources of Trypanosoma cruzi infection in rural northwestern Argentina. Parasitology 2007; 134:69–82.

  54. Gurtler RE, Cohen JE, Cecere MC, Lauricella MA, Chuit R, Segura EL. Influence of human and domestic animals on the household prevalence of Trypanosoma cruzi in Triatoma infestans populations in northwest Argentina. Am J Trop Med Hyg 1998; 59:748-758.

  55. Lopez-Olmos V, Pérez-Naser N, Piñero D, Ortega E, Hernández R, Espinoza B. Biological characterization and genetic diversity of Mexican isolates of Trypanosoma cruzi. Acta Tropica 1998; 69:239-254.

  56. Cortez-Jiménez M, Nogueda-Torres B, Alejandre-Aguilar, Isita-Torneli L, Ramírez-Moreno. Frequency of Triatomines Infected with Trypanosoma cruzi Collected in Cuernavaca City, Morelos, México. Rev Latinoam Microbiol 1996; 38: 115-19.

  57. Bautista NL, García de la Torre GS, De Haro I, Salazar PM. Importance of Triatoma pallidipennis (Hemíptera: Reduviidae) as a vector of T. cruzi (Kinetoplasta: Trypanosomatidae) in the state of Morelos, Mexico, possible ecotopes. J Med Entomol 1999; 36:233-35.

  58. Enger KS, Ordoñez R, Wilson ML, Ramsey JM. Evaluation of Risk Factors Rural Infectation by Triatoma pallidipennis (Hemiptera: Triatominae), a Mexican Vector of Chagas Disease. J Med Entomol 2004; 41:760-67.

  59. Villegas-Garcia JC, Santillán-Alarcón S. Role of Meccus pallidipennis Stal (1872) in the transmission of Trypanosoma cruzi to man in the state of Morelos, central Mexico. Entomol Vect 2004; 11:349-62.

  60. Zavala-Velázquez JE. La enfermedad de Chagas en el Estado de Yucatán, México (1940-2002). Rev Biomed 2003; 14:35-43.




2020     |     www.medigraphic.com